Patents by Inventor John Scott Karolchyk

John Scott Karolchyk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical ophthalmic compositions
    Patent number: 11684570
    Abstract: Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.
    Type: Grant
    Filed: August 11, 2022
    Date of Patent: June 27, 2023
    Assignees: NOVEL DRUG SOULTIONS LLC, EYE CARE NORTHWEST, PA
    Inventors: Jeffrey T. Liegner, John Scott Karolchyk, Bernard Covalesky, Richard Dilzer, Kalian Peters
  • PHARMACEUTICAL OPHTHALMIC COMPOSITIONS
    Publication number: 20220387308
    Abstract: Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: August 11, 2022
    Publication date: December 8, 2022
    Inventors: Jeffrey T. LIEGNER, John Scott KAROLCHYK, Bernard COVALESKY, Richard DILZER, Kallan PETERS
  • Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
    Patent number: 11510916
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as triamcinolone), at least one pharmaceutically acceptable excipient and a pharmaceutically acceptable carrier. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Grant
    Filed: October 28, 2020
    Date of Patent: November 29, 2022
    Assignees: NOVEL DRUG SOLUTIONS LLC, EYE CARE NORTHWEST, PA
    Inventors: Jeffrey T. Liegner, John Scott Karolchyk, Bernard Covalesky, Richard Dilzer, Kallan Kuper
  • Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
    Patent number: 11439590
    Abstract: Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: September 13, 2022
    Assignees: NOVEL DRUG SOLUTIONS LLC, PYP CAR NORTHWEST, PA
    Inventors: Jeffrey T. Liegner, John Scott Karolchyk, Bernard Covalesky, Richard Dilzer, Kallan Peters
  • Pharmaceutical formulations for the treatment of dry eye and methods for fabricating and using thereof
    Patent number: 11185546
    Abstract: Methods and kits for improving tear production are described, along with topical pharmaceutical compositions. In certain instances, the composition comprises pentoxifylline and a pharmaceutically acceptable carrier. The compositions also may further comprise another active agent, such as an anti-bacterial agent, antiviral agent, antifungal agent, or immunosuppressant agent, and combinations thereof.
    Type: Grant
    Filed: May 11, 2020
    Date of Patent: November 30, 2021
    Assignee: Harrow IP, LLC
    Inventors: John Scott Karolchyk, John P. Saharek
  • EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
    Publication number: 20210346318
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Application
    Filed: July 23, 2021
    Publication date: November 11, 2021
    Inventors: John Scott Karolchyk, Mark L. Baum, Dennis Saadeh
  • EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
    Publication number: 20210275471
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Application
    Filed: May 25, 2021
    Publication date: September 9, 2021
    Inventors: John Scott Karolchyk, Mark L. Baum
  • Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
    Patent number: 11045432
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: June 29, 2021
    Assignee: Harrow IP, LLC
    Inventors: John Scott Karolchyk, Mark L. Baum
  • Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
    Patent number: 10993921
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: May 4, 2021
    Inventors: John Scott Karolchyk, Mark L. Baum
  • PHARMACEUTICAL OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
    Publication number: 20210046001
    Abstract: Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: October 29, 2020
    Publication date: February 18, 2021
    Inventors: Jeffrey T. LIEGNER, John Scott KAROLCHYK, Bernard COVALESKY, Richard DILZER, Kallan PETERS, Dennis Elias Saadeh
  • PHARMACEUTICAL COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
    Publication number: 20210038592
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as triamcinolone), at least one pharmaceutically acceptable excipient and a pharmaceutically acceptable carrier. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Application
    Filed: October 28, 2020
    Publication date: February 11, 2021
    Inventors: Jeffrey T. LIEGNER, John Scott KAROLCHYK, Bernard COVALESKY, Richard DILZER, Kallan PETERS
  • PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF DRY EYE AND METHODS FOR FABRICATING AND USING THEREOF
    Publication number: 20200268763
    Abstract: Methods and kits for improving tear production are described, along with topical pharmaceutical compositions. In certain instances, the composition comprises pentoxifylline and a pharmaceutically acceptable carrier. The compositions also may further comprise another active agent, such as an anti-bacterial agent, antiviral agent, antifungal agent, or immunosuppressant agent, and combinations thereof.
    Type: Application
    Filed: May 11, 2020
    Publication date: August 27, 2020
    Inventors: John Scott Karolchyk, John P. Saharek
  • Pharmaceutical formulations for the treatment of dry eye and methods for fabricating and using thereof
    Patent number: 10695351
    Abstract: Methods and kits for improving tear production are described, along with topical pharmaceutical compositions. In certain instances the composition comprises pentoxifylline and a pharmaceutically acceptable carrier. The compositions also may further comprise another active agent, such as an anti-bacterial agent, antiviral agent, antifungal agent, or immunosuppressant agent, and combinations thereof.
    Type: Grant
    Filed: July 26, 2019
    Date of Patent: June 30, 2020
    Assignee: Harrow IP, LLC
    Inventors: John Scott Karolchyk, John P. Saharek
  • PHARMACEUTICAL COMPOSITIONS COMPRISING GELS AND METHODS FOR FABRICATING THEREOF
    Publication number: 20200155450
    Abstract: Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of an active component and a quantity of a sterile gel. Methods for fabricating the compositions and using them for ophthalmic or burn-treating applications are also described.
    Type: Application
    Filed: January 27, 2020
    Publication date: May 21, 2020
    Inventors: John Scott Karolchyk, Dennis Elias Saadeh
  • Pharmaceutical compositions comprising gels and methods for fabricating thereof
    Patent number: 10561607
    Abstract: Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of an active component and a quantity of a sterile gel. Methods for fabricating the compositions and using them for ophthalmic or burn-treating applications are also described.
    Type: Grant
    Filed: December 30, 2016
    Date of Patent: February 18, 2020
    Assignee: Harrow IP, LLC
    Inventor: John Scott Karolchyk
  • PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF DRY EYE AND METHODS FOR FABRICATING AND USING THEREOF
    Publication number: 20200030334
    Abstract: Methods and kits for improving tear production are described, along with topical pharmaceutical compositions. In certain instances the composition comprises pentoxifylline and a pharmaceutically acceptable carrier. The compositions also may further comprise another active agent, such as an anti-bacterial agent, antiviral agent, antifungal agent, or immunosuppressant agent, and combinations thereof.
    Type: Application
    Filed: July 26, 2019
    Publication date: January 30, 2020
    Inventors: John Scott Karolchyk, John P. Saharek
  • Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
    Patent number: 10285957
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Grant
    Filed: August 24, 2017
    Date of Patent: May 14, 2019
    Assignee: IMPRIMIS PHARMACEUTICALS, INC.
    Inventors: John Scott Karolchyk, Mark L. Baum
  • PHARMACEUTICAL OPHTHALMIC COMPOSITIONS AND METHODS FOR FABRICATING THEREOF
    Publication number: 20190111045
    Abstract: Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: May 3, 2017
    Publication date: April 18, 2019
    Inventors: William Wiley, Richard Dilzer, Dennis Elias Saadeh, Jeffrey T. Liegner, John Scott Karolchyk, Bernard Covalesky, Kallan Peters
  • EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
    Publication number: 20180055790
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Application
    Filed: August 24, 2017
    Publication date: March 1, 2018
    Inventors: John Scott Karolchyk, Mark L. Baum
  • PHARMACEUTICAL COMPOSITIONS COMPRISING GELS AND METHODS FOR FABRICATING THEREOF
    Publication number: 20170112936
    Abstract: Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of an active component and a quantity of a sterile gel. Methods for fabricating the compositions and using them for ophthalmic applications are also described.
    Type: Application
    Filed: January 5, 2017
    Publication date: April 27, 2017
    Inventors: John Scott Karolchyk, Dennis Elias Saadeh